281 related articles for article (PubMed ID: 27535331)
1. Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.
Holtman GA; Lisman-van Leeuwen Y; van Rheenen PF; Kollen BJ; Escher JC; Kindermann A; de Rijke YB; Berger MY
Fam Pract; 2017 Aug; 34(4):400-406. PubMed ID: 27535331
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
[TBL] [Abstract][Full Text] [Related]
3. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
Van de Vijver E; Schreuder AB; Cnossen WR; Muller Kobold AC; van Rheenen PF;
Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.
Otten CM; Kok L; Witteman BJ; Baumgarten R; Kampman E; Moons KG; de Wit NJ
Clin Chem Lab Med; 2008; 46(9):1275-80. PubMed ID: 18597588
[TBL] [Abstract][Full Text] [Related]
5. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.
Walker GJ; Chanchlani N; Thomas A; Lin S; Moore L; Heerasing NM; Hendy P; Abdelrahim M; Mole S; Perry MH; Mcdonald TJ; Bewshea CM; Hart JW; Russell RK; Ahmad T; Goodhand JR; Kennedy NA
Arch Dis Child; 2020 Oct; 105(10):957-963. PubMed ID: 32424002
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.
Menees SB; Powell C; Kurlander J; Goel A; Chey WD
Am J Gastroenterol; 2015 Mar; 110(3):444-54. PubMed ID: 25732419
[TBL] [Abstract][Full Text] [Related]
7. Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.
Walker GJ; Moore L; Heerasing N; Hendy P; Perry MH; McDonald TJ; Debenham T; Bethune R; Bewshea C; Hyde C; Heap GA; Singh A; Calvert C; Kennedy NA; Goodhand JR; Ahmad T
Aliment Pharmacol Ther; 2018 Apr; 47(8):1103-1116. PubMed ID: 29508423
[TBL] [Abstract][Full Text] [Related]
8. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease.
D'Incà R; Dal Pont E; Di Leo V; Ferronato A; Fries W; Vettorato MG; Martines D; Sturniolo GC
Int J Colorectal Dis; 2007 Apr; 22(4):429-37. PubMed ID: 16838143
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
[TBL] [Abstract][Full Text] [Related]
10. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
Heida A; Van de Vijver E; van Ravenzwaaij D; Van Biervliet S; Hummel TZ; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; van Rheenen PF;
Arch Dis Child; 2018 Jun; 103(6):565-571. PubMed ID: 29514815
[TBL] [Abstract][Full Text] [Related]
11. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
Sidler MA; Leach ST; Day AS
Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
[TBL] [Abstract][Full Text] [Related]
12. The use of fecal calprotectin and lactoferrin in patients with IBD. Review.
Stragier E; Van Assche G
Acta Gastroenterol Belg; 2013 Sep; 76(3):322-8. PubMed ID: 24261027
[TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease.
Joishy M; Davies I; Ahmed M; Wassel J; Davies K; Sayers A; Jenkins H
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay.
Diamanti A; Panetta F; Basso MS; Forgione A; Colistro F; Bracci F; Papadatou B; Francalanci P; Torroni F; Knafelz D; Fina F; Castro M
Inflamm Bowel Dis; 2010 Nov; 16(11):1926-30. PubMed ID: 20310017
[TBL] [Abstract][Full Text] [Related]
15. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
Schröder O; Naumann M; Shastri Y; Povse N; Stein J
Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care.
Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Walhout LC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
PLoS One; 2017; 12(12):e0189111. PubMed ID: 29211800
[TBL] [Abstract][Full Text] [Related]
18. Validation of Two Calprotectin Rapid Tests in Daily Routine.
Schulz C; Wex T; Arnim UV; Malfertheiner P
Clin Lab; 2016 Jul; 62(7):1249-1254. PubMed ID: 28164652
[TBL] [Abstract][Full Text] [Related]
19. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
[TBL] [Abstract][Full Text] [Related]
20. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
